BIOGEN INC. Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOGEN INC. for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 261.90 | 183 | 47,928 | 7,990 | 8.2 K to 8 K (-2.24 %) |
| Feb 26 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Sell | S | 261.90 | 84 | 22,000 | 8,127 | 8.2 K to 8.1 K (-1.02 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 1,149 | 0 | 3,462 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 579 | 0 | 4,611 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 258.99 | 273 | 70,704 | 26,870 | 27.1 K to 26.9 K (-1.01 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 579 | 0 | 27,143 | 26.6 K to 27.1 K (+2.18 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 132 | 0 | 402 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 66 | 0 | 534 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 258.99 | 22 | 5,698 | 2,687 | 2.7 K to 2.7 K (-0.81 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 66 | 0 | 2,709 | 2.6 K to 2.7 K (+2.50 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | J | 0.00 | 287 | 0 | 868 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 145 | 0 | 1,155 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Payment of Exercise | F | 258.99 | 48 | 12,432 | 2,549 | 2.6 K to 2.5 K (-1.85 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Buy | M | 0.00 | 145 | 0 | 2,597 | 2.5 K to 2.6 K (+5.91 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | J | 0.00 | 1,262 | 0 | 3,802 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 636 | 0 | 5,064 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 258.99 | 300 | 77,697 | 31,840 | 32.1 K to 31.8 K (-0.93 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 636 | 0 | 32,140 | 31.5 K to 32.1 K (+2.02 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 1,608 | 0 | 4,842 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 810 | 0 | 6,450 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 258.99 | 382 | 98,934 | 30,516 | 30.9 K to 30.5 K (-1.24 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 810 | 0 | 30,898 | 30.1 K to 30.9 K (+2.69 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Option Exercise | J | 0.00 | 597 | 0 | 1,802 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Option Exercise | M | 0.00 | 301 | 0 | 2,399 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Payment of Exercise | F | 258.99 | 98 | 25,381 | 1,865 | 2 K to 1.9 K (-4.99 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Buy | M | 0.00 | 301 | 0 | 1,963 | 1.7 K to 2 K (+18.11 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1,262 | 0 | 3,802 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 636 | 0 | 5,064 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 258.99 | 300 | 77,697 | 3,937 | 4.2 K to 3.9 K (-7.08 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 636 | 0 | 4,237 | 3.6 K to 4.2 K (+17.66 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | J | 0.00 | 1,149 | 0 | 3,462 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 579 | 0 | 4,611 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 258.99 | 273 | 70,704 | 8,326 | 8.6 K to 8.3 K (-3.17 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 579 | 0 | 8,599 | 8 K to 8.6 K (+7.22 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | J | 0.00 | 988 | 0 | 2,974 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | M | 0.00 | 498 | 0 | 3,962 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Payment of Exercise | F | 258.99 | 162 | 41,956 | 8,211 | 8.4 K to 8.2 K (-1.93 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Buy | M | 0.00 | 498 | 0 | 8,373 | 7.9 K to 8.4 K (+6.32 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 689 | 0 | 2,074 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 347 | 0 | 2,763 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 258.99 | 164 | 42,474 | 8,173 | 8.3 K to 8.2 K (-1.97 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 347 | 0 | 8,337 | 8 K to 8.3 K (+4.34 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | J | 0.00 | 5,884 | 0 | 17,702 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 2,964 | 0 | 23,586 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 258.99 | 1,395 | 361,291 | 61,417 | 62.8 K to 61.4 K (-2.22 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 2,964 | 0 | 62,812 | 59.8 K to 62.8 K (+4.95 %) |
| Feb 24 2016 | IDPH | BIOGEN INC. | Karaboutis Adriana | EVP, Tech, Bus. Sol ... | Option Exercise | A | 0.00 | 7,900 | 0 | 7,900 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | A | 0.00 | 7,270 | 0 | 7,270 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | A | 0.00 | 7,270 | 0 | 7,270 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 6,800 | 0 | 6,800 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | A | 0.00 | 7,900 | 0 | 7,900 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 870 | 0 | 870 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | A | 0.00 | 11,060 | 0 | 11,060 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 11,850 | 0 | 11,850 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | A | 0.00 | 40,460 | 0 | 40,460 | |
| Feb 24 2016 | IDPH | BIOGEN INC. | Koppel Adam | EVP, Strategy and B ... | Option Exercise | A | 0.00 | 7,270 | 0 | 7,270 | |
| Feb 19 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 256.16 | 487 | 124,750 | 59,848 | 60.3 K to 59.8 K (-0.81 %) |
| Feb 19 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 256.16 | 722 | 184,948 | 7,990 | 8.7 K to 8 K (-8.29 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | J | 0.00 | 5,982 | 0 | 10,502 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 9,189 | 0 | 9,182 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 4,512 | 0 | 16,484 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 247.22 | 5,359 | 1,324,852 | 60,335 | 65.7 K to 60.3 K (-8.16 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Grant | A | 0.00 | 11,390 | 0 | 65,694 | 54.3 K to 65.7 K (+20.97 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 247.22 | 4,324 | 1,068,979 | 54,304 | 58.6 K to 54.3 K (-7.38 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 9,189 | 0 | 58,628 | 49.4 K to 58.6 K (+18.59 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 247.22 | 2,132 | 527,073 | 49,439 | 51.6 K to 49.4 K (-4.13 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 4,512 | 0 | 51,571 | 47.1 K to 51.6 K (+9.59 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 1,394 | 0 | 2,448 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 2,246 | 0 | 2,249 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 1,052 | 0 | 3,842 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 247.22 | 1,057 | 261,312 | 30,088 | 31.1 K to 30.1 K (-3.39 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 2,246 | 0 | 31,145 | 28.9 K to 31.1 K (+7.77 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 247.22 | 495 | 122,374 | 28,899 | 29.4 K to 28.9 K (-1.68 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 1,052 | 0 | 29,394 | 28.3 K to 29.4 K (+3.71 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | J | 0.00 | 1,418 | 0 | 2,494 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,246 | 0 | 2,249 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 1,070 | 0 | 3,912 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 247.22 | 865 | 213,845 | 3,601 | 4.5 K to 3.6 K (-19.37 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 2,246 | 0 | 4,466 | 2.2 K to 4.5 K (+101.17 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 247.22 | 504 | 124,599 | 2,220 | 2.7 K to 2.2 K (-18.50 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 1,070 | 0 | 2,724 | 1.7 K to 2.7 K (+64.69 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 146 | 0 | 258 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 110 | 0 | 404 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 315 | 0 | 315 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 247.22 | 2 | 494 | 2,643 | 2.6 K to 2.6 K (-0.08 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 110 | 0 | 2,645 | 2.5 K to 2.6 K (+4.34 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 247.22 | 24 | 5,933 | 2,535 | 2.6 K to 2.5 K (-0.94 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 315 | 0 | 2,559 | 2.2 K to 2.6 K (+14.04 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 1,900 | 0 | 10,006 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | J | 0.00 | 759 | 0 | 1,336 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 792 | 0 | 797 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 573 | 0 | 2,095 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,434 | 0 | 11,906 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 247.22 | 373 | 92,213 | 8,712 | 9.1 K to 8.7 K (-4.11 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 792 | 0 | 9,085 | 8.3 K to 9.1 K (+9.55 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 247.22 | 270 | 66,749 | 8,293 | 8.6 K to 8.3 K (-3.15 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 573 | 0 | 8,563 | 8 K to 8.6 K (+7.17 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 247.22 | 556 | 137,454 | 7,990 | 8.5 K to 8 K (-6.51 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,434 | 0 | 8,546 | 7.1 K to 8.5 K (+20.16 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 247.22 | 628 | 155,254 | 7,112 | 7.7 K to 7.1 K (-8.11 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | J | 0.00 | 1,394 | 0 | 2,448 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,142 | 0 | 2,147 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 1,052 | 0 | 3,842 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 247.22 | 819 | 202,473 | 8,020 | 8.8 K to 8 K (-9.27 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,142 | 0 | 8,839 | 6.7 K to 8.8 K (+31.98 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 247.22 | 495 | 122,374 | 6,697 | 7.2 K to 6.7 K (-6.88 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 1,052 | 0 | 7,192 | 6.1 K to 7.2 K (+17.13 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | J | 0.00 | 1,521 | 0 | 2,674 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 2,142 | 0 | 2,147 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 1,147 | 0 | 4,195 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 247.22 | 788 | 194,809 | 31,504 | 32.3 K to 31.5 K (-2.44 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 2,142 | 0 | 32,292 | 30.2 K to 32.3 K (+7.10 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 247.22 | 540 | 133,499 | 30,150 | 30.7 K to 30.2 K (-1.76 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 1,147 | 0 | 30,690 | 29.5 K to 30.7 K (+3.88 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | J | 0.00 | 455 | 0 | 804 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 714 | 0 | 716 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 343 | 0 | 1,259 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Payment of Exercise | F | 247.22 | 240 | 59,333 | 2,452 | 2.7 K to 2.5 K (-8.92 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Buy | M | 0.00 | 714 | 0 | 2,692 | 2 K to 2.7 K (+36.10 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Payment of Exercise | F | 247.22 | 112 | 27,689 | 1,978 | 2.1 K to 2 K (-5.36 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Buy | M | 0.00 | 343 | 0 | 2,090 | 1.7 K to 2.1 K (+19.63 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | J | 0.00 | 1,394 | 0 | 2,448 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,807 | 0 | 2,808 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 1,052 | 0 | 3,842 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 247.22 | 1,204 | 297,653 | 26,564 | 27.8 K to 26.6 K (-4.34 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,807 | 0 | 27,768 | 25 K to 27.8 K (+11.25 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 247.22 | 495 | 122,374 | 24,961 | 25.5 K to 25 K (-1.94 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 1,052 | 0 | 25,456 | 24.4 K to 25.5 K (+4.31 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,274 | 0 | 0 | |
| Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 249.99 | 5,305 | 1,326,197 | 47,059 | 52.4 K to 47.1 K (-10.13 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 11,274 | 0 | 52,364 | 41.1 K to 52.4 K (+27.44 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Option Exercise | M | 0.00 | 1,278 | 0 | 0 | |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Sell | S | 246.54 | 852 | 210,052 | 7,740 | 8.6 K to 7.7 K (-9.92 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Payment of Exercise | F | 250.77 | 426 | 106,828 | 8,592 | 9 K to 8.6 K (-4.72 %) |
| Feb 10 2016 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP CMO Neuro & Neu ... | Buy | M | 0.00 | 1,278 | 0 | 9,018 | 7.7 K to 9 K (+16.51 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 2,498 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 250.77 | 822 | 206,133 | 29,543 | 30.4 K to 29.5 K (-2.71 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 2,498 | 0 | 30,365 | 27.9 K to 30.4 K (+8.96 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 3,194 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 250.77 | 1,047 | 262,556 | 24,404 | 25.5 K to 24.4 K (-4.11 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 3,194 | 0 | 25,451 | 22.3 K to 25.5 K (+14.35 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 4,026 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 250.77 | 1,324 | 332,019 | 28,342 | 29.7 K to 28.3 K (-4.46 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 4,026 | 0 | 29,666 | 25.6 K to 29.7 K (+15.70 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,709 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 250.77 | 890 | 223,185 | 6,140 | 7 K to 6.1 K (-12.66 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,709 | 0 | 7,030 | 4.3 K to 7 K (+62.69 %) |
| Feb 02 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,466 | 0 | 1 | |
| Feb 02 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 273.45 | 812 | 222,041 | 1,654 | 2.5 K to 1.7 K (-32.93 %) |
| Feb 02 2016 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 273.45 | 2,466 | 674,328 | 2,466 | 0 to 2.5 K |